SciELO - Scientific Electronic Library Online

 
vol.64 issue3Congenital infection by cytomegalovirus in newborns with very low birth weightCrisis of breast cancer cases detected in the second screening during the second year of the year of the pandemic in the Incan author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Salud Pública de México

Print version ISSN 0036-3634

Salud pública Méx vol.64 n.3 Cuernavaca May./Jun. 2022  Epub Oct 30, 2023

https://doi.org/10.21149/13698 

Cartas al editor

The last two cases of polio in México

Los dos últimos casos de polio en México

Victor Peña-Cruz, MD1  vpenac@bu.edu

(1) Department of Infectious Diseases, Boston Medical Center, Boston University. Boston, Massachusetts, USA.


Dear Editor: Epidemiological records of poliomyelitis in Mexico exist since 1937.1 To fight against the poliovirus, Mexico manufactured its own Salk vaccine in 1956.2 Since 1957 Dr. Sabin collaborated with Dr. Federico Gómez and Dr. Manuel Ramos Álvarez at Hospital Infantil de México. In 1958, a large-scale study was organized in four cities: Mexico City, Guadalajara, Monterrey and Puebla.3 In August 1959, the trivalent oral poliovirus vaccine (OPV) was tested in the city of Toluca, state of Mexico.4 By 1962 Mexico had manufactured its own OPV.

In the early 1960s, cases of vaccine associated paralytic polio (VAPP) were documented.5

In 1990, Mexico had seven cases of poliomyelitis, two are described here. On September 16th, a four month old boy from Tecomán in the state of Colima, became sick. On the 25th, a stool sample was taken and, on the 27th, he was hospitalized with acute flaccid paralysis. On October 5th, nerve conduction studies showed damage to the motor neurons of the anterior horn cells, affecting the left leg. The second patient, a 13 month old boy from Tomatlán in the state of Jalisco, on October 16thbecame sick. On the 23rd, stool samples were obtained; on October 24th, because of paralysis of both legs Gillian-Barré considered. On November 7th, nerve conduction studies showed damage of the motor neurons of the anterior horn cells. The families mentioned that the children were vaccinated. The question was: Were these cases due to vaccine or to wild polioviruses?

On 1990 Dr. Jesus Kumate was the head of the Health Ministry in Mexico. I was sent to the Centers for Disease Control and Prevention (CDC), Atlanta to diagnose the cause of the last two cases of flaccid paralysis. A polymerase chain reaction test (PCR) was performed with primers for the Sabin viruses and the design of genotype-specific PCR primer pairs of the VP1 nucleotide sequences from the PV3/9288/MEX89 were constructed at the CDC.6 Table I shows that the viruses were wild polio Leon.

Table I Wild type Leon polioviruses from México and Sabin viruses amplified by PCR 

Strain

Provenance

PCR amplification products

53bp

71bp

97bp

163bp

PV3/0380/MEX90

Tomatlán, Jalisco

-

-

-

+

PV3/0377/MEX90

Tecomán, Colima

-

-

-

+

PV3/9288/MEX89

Novolato, Sinaloa

-

-

-

+

SABIN3

CDC Atlanta

+

-

-

-

SABIN2

CDC Atlanta

-

+

-

-

SABIN1

CDC Atlanta

-

-

+

-

The polymerase chain reaction (PCR) amplification products are indicated as positive or negative after being expressed by a representation of the electrophoresis on a 12% polyacrylamide gel (gel not shown). Primer pairs for the Mexican virus were as follows: 9288/PCR-1 + 0288/PCR-2.The primer pairs for the Sabin virus: Sabin3/PCR-1 + Sabin3/PCR-2; Sabin2/PCR-1 + Sabin2/PCR-2 and Sabin1/PCR-1 + Sabin1/PCR-2.

This table was originated from the electrophoresis results in 1991.

CDC: Centers for Disease Control and Prevention.

Acknowledgement

I thank Dr. Olen Kew (CDC) for hosting me in his lab and his valuable assistance with the molecular techniques and the use of the primers to characterize the polioviruses. Enid Ramírez provided information on the children’s records (INDRE, México).

References

Ortiz-Mariotte C, Calderón C, Ornelas-Hernández A. Situación del problema de la poliomielitis en México. Bol Oficina Sanit Panam. 1953;35(4):396-409. [ Links ]

Gutiérrez-Villegas L. Resultado de la vacuna contra la poliomielitis, tipo Salk, elaborada en México. Gac Med Mex. 1958;88:319-31. [ Links ]

Ramos-Álvarez M, Bustamante ME, Álvarez-Alba R. The use of the Sabin vaccine, of live poliomyelitis virus, in Mexico: results of a large scale study. Bol Oficina Sanit Panam . 1961;50:305-22. [ Links ]

Sabin AB, Ramos-Álvarez M, Álvarez-Amezquita J, Pelon W, Michaels RH, Spigland I, et al. Live, orally given poliovirus vaccine. Effects of rapid mass immunizations on population under conditions of massive enteric infection with other viruses. JAMA. 1960;173(14):1521-6. https://doi.org/10.1001/jama.1960.03020320001001 [ Links ]

Henderson DA, Witte JJ, Morris L, Langmuir AD. Paralytic disease associated with oral polio vaccines. JAMA . 1964;190(1):41-8. https://doi.org/10.1001/jama.1964.03070140047006 [ Links ]

Chen-Fu Y, Lina D, Su-Ju Y, Ruiz-Gómez J, Cruz-José R, Holloway BP, et al. Genotype-specific in vitro amplification of sequences of the wild type 3 polioviruses from Mexico and Guatemala. Virus Research. 1992;24(3):277-96. https://doi.org/10.1016/0168-1702(92)90124-r [ Links ]

Declaration of conflict of interests. The author declares not to have conflict of interests.

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License